I-milk-thistle ibonisa isithembiso sokuvikela isifo sikashukela kanye nesifo sikashukela, kuhlanganise nokulimala kwezinso kanye nemithwalo yegazi. Ngokuvame ukusetshenziselwa ukwandisa impilo yebindi kanye nemizamo yokusekela i-detox, ubisi lwe-thistle lucebile kuma-antioxidants (izinto zemvelo ziyaziwa ngokuthi zikhiphe ama-radicals mahhala ). Kanti, izinkinga eziningi ezihlobene nesifo sikashukela zixhunyaniswe nokucindezeleka kwe-oxidative (inqubo ephumela ekukhuculeni kwama-radicals mahhala).
Ngokuvikela ekucindezelekeni kwe-oxidative, ucwaningo lubonisa ukuthi ubisi lwe-thistle lungasiza ekwelapheni isifo sikashukela.
Ukucwaninga nge-Milk Thistle for Diabetes
Kuze kube manje, ezimbalwa izifundo ziye zahlola imiphumela yobisi lwe-thistle kubantu abanesifo sikashukela. Ucwaningo olutholakalayo lubandakanya ucwaningo luka-2006 (olushicilelwe ku- Phytotherapy Research ), olubandakanya abantu abangu-51 abanesifo sikashukela sohlobo lwesi-2. Kwaphela izinyanga ezine, ababambiqhaza bahlanganisa ukwelashwa kwabo okuvamile nge-placebo noma isithako esine-silymarin (i-antioxidant complex ekhishwe ubisi thistle). Ngokuphela kokucwaninga, amalungu eqembu le-silymarin abonisa ukwehla okukhulu kwe- cholesterol kanye ne-LDL ("okubi") ye-cholesterol. Ngaphezu kwalokho, u-silymarin wabonakala ukusiza ukulawula amazinga ashukela egazini.
Ukuhlola i-Laboratory kusikisela ukuthi ubisi lwe-thistle lungasiza futhi ukuphatha isifo sikashukela ngokuphatha ukuphikiswa kwe-insulin . Ngombiko wango-2005 owashicilelwa kwi- Medical Hypotheses , isibonelo, ososayensi bayaqaphela ukuthi kokubili i-silibinin (i-antioxidant etholakala ku-silymarin) ne-resveratrol (i-antioxidant etholakalayo esikhunjeni samagilebhisi abomvu) ingasiza ekuvuseleleni ukumelana kwe-insulin ngokusebenza ne-IKKbeta (i-enzyme eboniswe ukuphazamisa ukusayina kwe-insulin).
Ukwengeza, kunobunye ubufakazi bokuthi u-milk thistle angasiza ekunqandeni ukulimala kwezinso ezihlobene nesifo sikashukela (isimo esibizwa ngokuthi i-nephropathy yesifo sikashukela). Isibonelo, isifundo sezilwane eshicilelwe ukuhluleka kwe-Renal ngo-2010 sibonise ukuthi ubisi lwe-thistle lwancipha ukuqhubekela phambili kwe-nephropathy yesifo sikashukela eqenjini lamagundane.
Amapulangwe
Ngenxa yokuntuleka kocwaningo, kuncane okuyaziwa ngokuphepha kokusetshenziswa kabuhlungu ubisi lwe-thistle. Kubalulekile ukukhumbula ukuthi ama-supplements awazange ahlolwe ukuphepha kanye nezondlo zokudla ngokuvamile azihambisani nomthetho. Kwezinye izimo, umkhiqizo ungase ulethe ukulinganisa okungafani nesilinganiso esicacisiwe semifino ngayinye. Kwezinye izimo, umkhiqizo ungangcoliswa nezinye izinto ezifana nezensimbi. Futhi, ukuphepha kwezidakamizwa kwabesifazane abakhulelwe, omama abahlengikazi, izingane, nalabo abanezimo zezokwelapha noma abaphuza imishanguzo azange zisungulwe.
Ukusebenzisa ubisi lwezinyosi zesifo sikashukela
I-Institutes of Health kazwelonke ihlukanisa ubisi thistle ngokuthi "kungenzeka ukuthi iphumelele" yesifo sikashukela. Kodwa-ke, ukusebenzisa uketshezi ubisi endaweni yokwelashwa okunqunywe yisifo sikashukela kungaba nemiphumela emibi yezempilo. Uma ucabangela ukusebenzisa ubisi thistle (noma yimuphi omunye umuthi we-herbal) ekwelapheni isifo sikashukela, kubalulekile ukubonana nodokotela wakho ngaphambi kokuqala uhlelo lwakho lokuxhaswa.
Imithombo
Huseini HF, Larijani B, Heshmat R, Fakhrzadeh H, Radjabipour B, Toliat T, Raza M. "Ukuphumelela kukaSilybum marianum (L.) Gaertn. (Silymarin) ekwelapheni uhlobo lwesifo sikashukela: i-randomized, double-blind , ukulawulwa kwe-placebo, ukuvivinywa komtholampilo. " I-Phytother Res. 2006 Dec; 20 (12): 1036-9.
McCarty MF. "Kungenzeka ukuthi i-polyphenol yemvelo ingasetshenziswa ekuvuseleleni ukungenwa kwe-insulin okubangelwa amafutha." Bonisa ama-hypothetical. 2005; 64 (3): 628-35.
Izikhungo zezempilo zikazwelonke. "Umswakama wobisi: Izithako ze-MedlinePlus". Januwari 2011.
Vessal G, Akmali M, Najafi P, Moein MR, Sagheb MM. "I-Silymarin nobisi be-thistle ekhishwe kungavimbela ukuqhuma kwe-nephropathy yesifo sikashukela kumagundane ayisifo sikashukela e-streptozotocin." Ren Fail. 2010 Jul; 32 (6): 733-9.
Ukuziphendulela: Ulwazi oluqukethwe kule sayithi luhloswe ngezinjongo zemfundo kuphela futhi aluthathi iseluleko, ukuxilongwa noma ukwelashwa ngudokotela olayisensi. Akuhloselwe ukumboza zonke izinyathelo zokuqapha, ukusebenzisana kwezidakamizwa, izimo noma imiphumela emibi. Kufanele ufune ukunakekelwa okusheshayo kwezokwelapha kunoma yiziphi izinkinga zezempilo bese uthintana nodokotela wakho ngaphambi kokusebenzisa enye imithi noma wenze ushintsho ohlelweni lwakho.